Aspen Pharmacare Holdings Ltd (APN) - Total Liabilities
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has total liabilities worth ZAC46.96 Billion ZAC (≈ $24.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore APN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Aspen Pharmacare Holdings Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Aspen Pharmacare Holdings Ltd asset portfolio.
Aspen Pharmacare Holdings Ltd Competitors by Total Liabilities
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
S N Nuclearele
RO:SNN
|
Romania | RON1.73 Billion |
|
Tangshan Port Group Co Ltd
SHG:601000
|
China | CN¥2.15 Billion |
|
Unifirst Corporation
NYSE:UNF
|
USA | $622.65 Million |
|
DMG MORI AKTIENGESELLSCHAFT
XETRA:GIL
|
Germany | €1.06 Billion |
|
USA Compression Partners LP
NYSE:USAC
|
USA | $3.40 Billion |
|
Otter Tail Corporation
NASDAQ:OTTR
|
USA | $2.42 Billion |
|
Doosan Bobcat Inc
KO:241560
|
Korea | ₩5.73 Trillion |
|
Sigurd Microelectronics Corp
TW:6257
|
Taiwan | NT$22.02 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Aspen Pharmacare Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See APN equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aspen Pharmacare Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual total liabilities of Aspen Pharmacare Holdings Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | ZAC51.00 Billion ≈ $27.10 Million |
-6.07% |
| 2024-06-30 | ZAC54.29 Billion ≈ $28.85 Million |
+13.00% |
| 2023-06-30 | ZAC48.05 Billion ≈ $25.54 Million |
+18.83% |
| 2022-06-30 | ZAC40.43 Billion ≈ $21.49 Million |
-8.23% |
| 2021-06-30 | ZAC44.06 Billion ≈ $23.41 Million |
-31.11% |
| 2020-06-30 | ZAC63.95 Billion ≈ $33.99 Million |
-6.10% |
| 2019-06-30 | ZAC68.10 Billion ≈ $36.19 Million |
-17.69% |
| 2018-06-30 | ZAC82.74 Billion ≈ $43.97 Million |
+13.03% |
| 2017-06-30 | ZAC73.20 Billion ≈ $38.90 Million |
+18.45% |
| 2016-06-30 | ZAC61.80 Billion ≈ $32.84 Million |
+13.90% |
| 2015-06-30 | ZAC54.26 Billion ≈ $28.83 Million |
+1.09% |
| 2014-06-30 | ZAC53.67 Billion ≈ $28.52 Million |
+137.24% |
| 2013-06-30 | ZAC22.62 Billion ≈ $12.02 Million |
+57.98% |
| 2012-06-30 | ZAC14.32 Billion ≈ $7.61 Million |
+6.00% |
| 2011-06-30 | ZAC13.51 Billion ≈ $7.18 Million |
+51.55% |
| 2010-06-30 | ZAC8.91 Billion ≈ $4.74 Million |
+7.94% |
| 2009-06-30 | ZAC8.26 Billion ≈ $4.39 Million |
+9.68% |
| 2008-06-30 | ZAC7.53 Billion ≈ $4.00 Million |
+46.42% |
| 2007-06-30 | ZAC5.14 Billion ≈ $2.73 Million |
+102.17% |
| 2006-06-30 | ZAC2.54 Billion ≈ $1.35 Million |
+25.33% |
| 2005-06-30 | ZAC2.03 Billion ≈ $1.08 Million |
+94.55% |
| 2004-06-30 | ZAC1.04 Billion ≈ $554.39K |
+17.64% |
| 2003-06-30 | ZAC886.73 Million ≈ $471.25K |
-- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more